Medical care of type 2 diabetes in German Disease Management Programmes: A population-based evaluation

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 4, 2011, Pages 383-391

  Stark, Reneé G ^a   Schunk, Michaela V ^a   Meisinger, Christine ^a   Rathmann, Wolfgang ^b   Leidl, Reiner ^a,c   Holle, Rolf ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Disease management; Medical care; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET THERAPY; DISEASE DURATION; EDUCATIONAL STATUS; EVIDENCE BASED MEDICINE; EYE EXAMINATION; FEMALE; FOOT; GERMANY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL INSURANCE; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; FEMALE; GERMANY; HEALTH CARE SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT EDUCATION AS TOPIC; QUALITY CONTROL; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 79955732841     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1186     Document Type: Article

References (32)

1. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002; 288: 1775-1779.
2. Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005; 43: 436-444.
3. Legal stipulations regarding disease management programs. 2009; [11 No-vember 2009].
4. Evaluation criteria stipulated by the federal social insurance authority. 2009; [4 December 2009].
5. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32(Suppl. 1): S13-S61.
6. Performance criteria of the 2009 Diabetes Recognition Program. 2009; [3 December 2009].
7. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 2001; 24: 1815-1820.
8. Changes to the Diabetes Recognition Program-frequently asked questions. 2010; [15 November 2010].
9. UKPDS risk engine. 2010; [19 March 2010].
10. Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33: 1776-1781.
11. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671-679.
12. Ullrich W, Marschall U, Graf C. Versor-gungsmerkmale des diabetes mellitus in Disease-Management-Programmen. Diabetes, Stoffwechsel Herz 2007; 16: 407-414.
13. Szecsenyi J, Rosemann T, Joos S, Peters-Klimm F, Miksch A. German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument. Diabetes Care 2008; 31: 1150-1154.
14. Holle R, Happich M, Lowel H, Wichmann HE. KORA-a research platform for population based health research. Gesundheitswesen 2005; 67(Suppl. 1): S19-S25.
15. Information regarding the KORA Study Platform. 2010; [15 November 2010].
16. Lamers LM, van Vliet RC. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy 2004; 68: 113-121.
17. Holle R, Hochadel M, Reitmeir P, Meisinger C, Wichmann HE. Prolonged recruitment efforts in health surveys: effects on response, costs, and potential bias. Epidemiology 2006; 17: 639-643.
18. Stark R, Schunk M, Leidl R, Meisinger C, Holle R. Process evaluation of disease management programs for type 2 diabetes based on a representative population in the area of Augsburg (KORA). Betriebswirtschaftliche Forsch Praxis 2009; 3: 283-301.
19. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189.
20. Dunkelberg S, Zingel D, Noack A, van den Bussche H, Kaduszkiewicz H. Which patients are (not) included in the DMP diabetes programme? Gesundheitswesen 2006; 68: 289-293.
21. Knight K, Badamgarav E, Henning JM, et al. A systematic review of diabetes disease management programs. Am J Manag Care 2005; 11: 242-250.
22. Shortell SM, Gillies R, Siddique J, et al. Improving chronic illness care: a longitudinal cohort analysis of large physician organizations. Med Care 2009; 47: 932-939.
23. Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362: 1575-1585.
24. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
25. Rothe U, Muller G, Schwarz PE, et al. Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research. Diabetes Care 2008; 31: 863-868.
26. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
27. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
28. Ahmann AJ. Guidelines and performance measures for diabetes. Am J Manag Care 2007; 13(Suppl. 2): S41-S46.
29. Goderis G, Borgermans L, Grol R, et al. Start improving the quality of care for people with type 2 diabetes through a general practice support program: a cluster randomized trial. Diabetes Res Clin Pract 2010; 88: 56-64.
30. Peterson KA, Radosevich DM, O'Connor PJ, et al. Improving diabetes care in practice: findings from the TRANSLATE trial. Diabetes Care 2008; 31: 2238-2243.
31. Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18, 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371: 117-125.
32. Quality assurance indicators for disease management programs. 2009; [4 December 2009].